The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear¥17.65Fair value¥183.56Bull¥299.20
FairClose
52-week traded range
52W low ¥228.0052W high ¥320.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading above the consensus fair value
Medical Net,Inc. closed at ¥263.00, 43.3% above the consensus fair value of ¥183.56 drawn from 9 valuation models.
Financial DNA score 43/100 — Average. P/E of 17.6x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
¥123.25
-53.1%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=1.2%, r=10%, tg=3%, n=10yr
Graham Number
¥269.37
+2.4%
√(22.5 × EPS × BVPS)
EPS=14.96, BVPS=215.57
P/E Fair Value
¥299.20
+13.8%
EPS × 20x (sector P/E)
EPS=14.96, Sector P/E=20x
Peter Lynch (PEG)
¥17.65
-93.3%
EPS × Growth% (PEG = 1 is fair)
EPS=14.96, g=1.2%
EV/EBITDA
¥107.18
-59.2%
(EBITDA × 10.6x − Net Debt) ÷ Shares
EBITDA=220.88M
Dividend Discount (DDM)
¥38.23
-85.5%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=3, r=10%, g=2%
Book Value (P/B)
¥135.81
-48.4%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=215.57, ROE=7.4%, g=3%, r=10%
Reverse DCF
¥263.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 5.4% | Historical: 1.2%
Margin of Safety
¥172.95
-34.2%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=230.61, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.